z-logo
open-access-imgOpen Access
High Phenobarbital Clearance During Continuous Renal Replacement Therapy
Author(s) -
Staffan Rosenborg,
L. Saraste,
Katarina Wide
Publication year - 2014
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000000046
Subject(s) - medicine , phenobarbital , renal replacement therapy , dosing , therapeutic drug monitoring , status epilepticus , therapeutic index , respiratory failure , epilepsy , anesthesia , intensive care medicine , drug , pharmacology , psychiatry
Abstract Phenobarbital is an old antiepileptic drug used in severe epilepsy. Despite this, little is written about the need for dose adjustments in renal replacement therapy. Most sources recommend a moderately increased dose guided by therapeutic drug monitoring. A 14 year old boy with nonketotic hyperglycinemia, a rare inborn error of metabolism, characterized by high levels of glycine, epilepsy, spasticity, and cognitive impairment, was admitted to the emergency department with respiratory failure after a few days of fever and cough. The boy was unconscious at admittance and had acute renal and hepatic failure. Due to the acute respiratory infection, hypoxic hepatic and renal failure occurred and the patient had a status epilepticus. The patient was intubated and mechanically ventilated. Continuous renal replacement therapy was initiated. Despite increased phenobarbital doses, therapeutic levels were not reached until the dose was increased to 500 mg twice daily. Therapeutic drug monitoring was performed in plasma and dialysate. Calculations revealed that phenobarbital was almost freely dialyzed. Correct dosing of drugs in patients on renal replacement therapy may need a multidisciplinary approach and guidance by therapeutic drug monitoring.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here